Management tracks: Verastem CEO Forrester steps down; plus Recursion, N8 Medical

Verastem Inc. (NASDAQ:VSTM) said Robert Forrester will step down as president and CEO. COO Dan Paterson will succeed Forrester as president and lead the executive team while the board searches for a permanent successor. The cancer company also said Rob Gagnon will become CBO in addition to his role as CFO.

AI company Recursion Pharmaceuticals Inc. (Salt Lake City, Utah) hired Sharath Hegde as CSO. He was SVP of research at Theravance Biopharma Inc. (NASDAQ:TBPH). The CSO position has been vacant since co-founder Dean Li, who remains an adviser, stepped down. ...